XTX Topco Ltd bought a new stake in shares of The Allstate Corporation (NYSE:ALL - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,794 shares of the insurance provider's stock, valued at approximately $786,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of ALL. Price T Rowe Associates Inc. MD lifted its holdings in shares of Allstate by 2.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider's stock valued at $1,799,681,000 after acquiring an additional 218,771 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Allstate by 157.9% in the 4th quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock valued at $1,270,705,000 after purchasing an additional 4,035,629 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Allstate by 3.0% during the 4th quarter. Invesco Ltd. now owns 3,681,306 shares of the insurance provider's stock worth $709,719,000 after purchasing an additional 106,730 shares during the last quarter. Northern Trust Corp boosted its stake in Allstate by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,496,017 shares of the insurance provider's stock valued at $673,997,000 after acquiring an additional 477,221 shares in the last quarter. Finally, Deutsche Bank AG raised its stake in Allstate by 7.2% in the fourth quarter. Deutsche Bank AG now owns 3,233,681 shares of the insurance provider's stock valued at $623,421,000 after buying an additional 217,468 shares during the last quarter. 76.47% of the stock is owned by institutional investors.
Allstate Price Performance
Shares of ALL traded up $2.48 on Tuesday, reaching $205.51. The stock had a trading volume of 1,781,515 shares, compared to its average volume of 1,718,708. The Allstate Corporation has a twelve month low of $169.20 and a twelve month high of $213.18. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average of $198.36 and a 200 day moving average of $197.41. The firm has a market capitalization of $54.15 billion, a PE ratio of 9.66, a PEG ratio of 0.87 and a beta of 0.35.
Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.20 by $2.74. The company had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The firm's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.61 EPS. Sell-side analysts expect that The Allstate Corporation will post 18.74 EPS for the current year.
Allstate Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be paid a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Friday, August 29th. Allstate's payout ratio is currently 18.81%.
Analysts Set New Price Targets
A number of research firms have weighed in on ALL. Evercore ISI lifted their price objective on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Morgan Stanley boosted their price objective on Allstate from $235.00 to $245.00 and gave the stock an "overweight" rating in a research note on Friday. BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a research report on Friday, May 16th. Keefe, Bruyette & Woods raised their price target on Allstate from $235.00 to $237.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Finally, JPMorgan Chase & Co. boosted their target price on Allstate from $217.00 to $222.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $229.40.
View Our Latest Report on ALL
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.